AstraZeneca Taps New Comms, Gov't Affairs Execs
Charting the future of public relations
Holmes Report
CEO

AstraZeneca Taps New Comms, Gov't Affairs Execs

Pharmaceutical company AstraZeneca has named David Nicoli vice president of communications and external relations and Marion McCourt vice president of government affairs, policy and managed markets.

Paul Holmes

WILMINGTON, DE—Pharmaceutical company AstraZeneca has named David Nicoli vice president of communications and external relations and Marion McCourt vice president of government affairs, policy and managed markets, following a decision earlier this year to separate the two functions.

David Nicoli joins the company from New York-based Altria Group—the former Philip Morris—where he most recently served as vice president, corporate communications. He joined Altria in 1991 and during his 12-year tenure held a number of leadership positions including vice president, corporate affairs strategy and social responsibility, issues management and government affairs. 

Previously, Nicoli, an attorney by training, was an associate at several law firms, including Arnold & Porter in Washington, D.C.

McCourt most recently served as vice president, managed markets, and had responsibility for leading the managed markets business group.  Her appointment, to a new position, follows the announcement that Alan Milbauer, vice president of public affairs, is retiring after 32 years of service. Milbauer was responsible for both the government and public affairs functions in the U.S. 

“Our decision to combine government affairs with managed markets makes particularly good sense in today’s changing healthcare environment,” says AstraZeneca chief executive David Brennan. “It is critical for AstraZeneca to effectively adapt to these changes and find areas to take leadership, especially in light of Medicare reform.”

View Style:

Load 3 More
comments powered by Disqus